
Healthcare / Pharmaceuticals · NSE / BSE
Amanta Healthcare Limited, founded in December 1994, is a pharmaceutical company engaged in developing, manufacturing, and marketing sterile liquid products, mainly parenteral formulations, using advanced Aseptic Blow-Fill-Seal and Injection Stretch Blow Moulding technologies. The company also produces medical devices and offers a wide range of products including IV fluids, diluents, ophthalmic solutions, respiratory care products, irrigation solutions, first-aid items, and eye lubricants. Its business is divided into three units: national sales, international sales, and product partnerships with Indian and global pharmaceutical companies. Amanta manufactures over 45 generic products, distributed across India through 320 distributors and stockists, while also exporting to Africa, Latin America, the UK, and other regions. Its products are registered in 19 countries, and in Fiscal 2025, it exported branded products to 21 countries. As of March 31, 2025, the company employed 1,718 people across its formulation, development, and quality laboratories.
Price Band
₹120 – ₹126
Issue Size
₹126 Cr
Lot Size
119 shares
GMP
+7.1%
Est. Listing
₹135
at current GMP
Subscribed
82.61x
overall
Open
1 Sep 2025
Close
3 Sep 2025
Allotment
4 Sep 2025
Refund
5 Sep 2025
Demat Credit
6 Sep 2025
Listing
9 Sep 2025
Overall Subscription
82.61x
Total Demand
QIB Multiplier
35.86x
Institutions & Funds
NII / HNI
209.42x
High Net-Worth
Retail (RII)
54.98x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 2,000,000 | 71,722,490 | 35.86x |
| NIB | 1,500,000 | 314,135,486 | 209.42x |
| HNIs(10L +) | 1,000,000 | 226,127,251 | 226.13x |
| HNIs (2-10L) | 500,000 | 88,008,235 | 176.02x |
| RETAIL | 3,500,000 | 192,422,762 | 54.98x |
| Total | 8,500,000 | 892,416,224 | 82.61x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| RETAIL | 29,412 | 1,329,970 | 45.22x |
| HNIs(10L +) | 600 | 27,311 | 45.52x |
| HNIs (2-10L) | 300 | 50,755 | 169.18x |
| Total Applications | 30,312 | 1,408,036 | 46.45x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Amanta Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹126 Crores. The shares are offered at a price band of ₹120 to ₹126 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-09-03, the basis of allotment is scheduled to be finalized on 2025-09-04. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
The latest Grey Market Premium (GMP) for Amanta Healthcare Limited IPO is ₹9 per equity share. Based on the upper price band of ₹120 to ₹126 per equity share, the estimated listing price is ₹135 (+7.1% expected listing gain).
With a lot size of 119 shares and current GMP of ₹9, the expected profit per application lot is approx ₹1,071 (+7.1% gain). Minimum application cost is approx ₹14,994.
The Amanta Healthcare Limited IPO aggregate issue size is ₹126 Crores with an equity price band set at ₹120 to ₹126 per equity share. The retail lot size is 119 shares requiring a minimum capital outlay of approx. ₹14,994.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 82.61x (Retail: 54.98x, QIB: 35.86x, NII: 209.42x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2025-09-04. Investors can verify status using PAN card or application number.
Amanta Healthcare Limited shares are scheduled to list on NSE and BSE on 2025-09-09.